Safety, Resource Use, And Quality Of Life (Qol) Results From Paramount: A Phase Iii Study Of Maintenance Pemetrexed Plus Best Supportive Care (Bsc) Versus Placebo Plus Bsc Immediately Following Induction Treatment With Pemetrexed-Cisplatin For Advanced Nonsquamous Non-Small Cell Lung Cancer (Nsclc)